Arcadia Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Arcadia Biosciences has a total shareholder equity of $12.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $19.7M and $7.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$11.64m |
| Equity | US$12.70m |
| Total liabilities | US$7.00m |
| Total assets | US$19.71m |
Recent financial health updates
Recent updates
We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely
Mar 01
Arcadia Biosciences to raise $5M in securities offering
Aug 15Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings
Nov 29We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit
Nov 22The Future Looks Bright For Arcadia Biosciences
Dec 01Arcadia Biosciences EPS misses by $0.06
Nov 12Financial Position Analysis
Short Term Liabilities: RKDA's short term assets ($15.0M) exceed its short term liabilities ($3.6M).
Long Term Liabilities: RKDA's short term assets ($15.0M) exceed its long term liabilities ($3.4M).
Debt to Equity History and Analysis
Debt Level: RKDA is debt free.
Reducing Debt: RKDA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RKDA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RKDA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 3.1% each year